Gadot Biochemical Industries predicts high winter demand for zinc

Gadot is positioned to supply zinc for current and new global retail products expected to include zinc in its formulations. 

Gadot Biochemical Industries, an Israel-based supplier of zinc for dietary supplements and foods, has announced that it expects high winter demand for zinc and is ready to fulfill the product pipeline for the immune-support season.

Overall, Gadot experienced massive growth in global mineral sales at the end of Q2 2022 over last year, according to Ohad Cohen, CEO of Gadot. 

“Zinc sales are skyrocketing for immunity purposes. New products launched in the last five years in the healthcare category have increased by more than 68%, according to a well-known global marketing research firm,” remarked Cohen. “Zinc is a perfect match for botanical and plant-based formulations since the ingredient offers abundant health benefits and scientific claims. And we do not have supply chain issues.”

Cohen further noted additional marketing research numbers: trending claims of products containing zinc were in the plant-based category, with 600% growth in the last five years and 500% growth in herbal/botanical products with zinc. Worldwide, new product launches containing zinc have grown significantly, with Europe leading the pack at 190, followed by North America at 48.

The body of research validating zinc’s role in immune health supports its critical role in dietary supplementation that targets overall healthy resistance that consumers seek during the winter months,” Cohen emphasised.

For decades, Cohen pointed out, zinc has been a primary ingredient consumers turn to for immune function benefits. The RDA for adults for zinc (15mg elemental zinc daily) was established in 1974. Since then, numerous studies have demonstrated its ability to support normal development and function of cells that mediate innate and adaptive immunity, neutrophils, NK cells, and macrophages. Further studies have shown that zinc can modulate oxidative stress and inhibit inflammatory cytokines. When there is not enough zinc in the body, the result is an impairment of phagocytosis, intracellular killing, and cytokine production1.

The recommended daily allowance (RDA) set by the Food and Drug Administration for zinc recommends that women aged 19 and up consume 8mg of zinc per day (with 11mg for pregnant and 12mg for lactating women) while men should get 11mg per day. The RDA for zinc in the EU is 10mg. The Codex Alimentations International Food Standard nutrient reference value (NRV) recommends 11-14mg of zinc depending on one’s diet.

Zinc is a mineral with many more important roles in promoting homeostasis. Research has also shown that zinc is necessary to support healthy neurosensory performance, lean body mass, proper growth in children, bone morphology, and cognitive function. It is also involved in healthy skin and nail structure.

The EFSA’s scientific opinion on zinc is abundant with diverse claims based on scientific substantiation, including but not limited to the metabolism of fatty acids, joint maintenance, cardiovascular function, prostate function, thyroid function, vitamin A metabolism, and vision function, as well as protection of DNA, proteins, and lipids from oxidative damage2.

“It is clear that zinc is a powerhouse mineral for human health,” commented Cohen.


1 Prasad, “Zinc in Human Health: Effect of Zinc on Immune Cells” Molecular Medicine 2008 14(5-6):353-357

2 EFSA Journal 2009; 7(9):1229